» Articles » PMID: 37386075

Parabacteroides Distasonis Uses Dietary Inulin to Suppress NASH Via Its Metabolite Pentadecanoic Acid

Overview
Journal Nat Microbiol
Date 2023 Jun 29
PMID 37386075
Authors
Affiliations
Soon will be listed here.
Abstract

Non-alcoholic steatohepatitis (NASH) is the severe form of non-alcoholic fatty liver disease, and is characterized by liver inflammation and fat accumulation. Dietary interventions, such as fibre, have been shown to alleviate this metabolic disorder in mice via the gut microbiota. Here, we investigated the mechanistic role of the gut microbiota in ameliorating NASH via dietary fibre in mice. Soluble fibre inulin was found to be more effective than insoluble fibre cellulose to suppress NASH progression in mice, as shown by reduced hepatic steatosis, necro-inflammation, ballooning and fibrosis. We employed stable isotope probing to trace the incorporation of C-inulin into gut bacterial genomes and metabolites during NASH progression. Shotgun metagenome sequencing revealed that the commensal Parabacteroides distasonis was enriched by C-inulin. Integration of C-inulin metagenomes and metabolomes suggested that P. distasonis used inulin to produce pentadecanoic acid, an odd-chain fatty acid, which was confirmed in vitro and in germ-free mice. P. distasonis or pentadecanoic acid was protective against NASH in mice. Mechanistically, inulin, P. distasonis or pentadecanoic acid restored gut barrier function in NASH models, which reduced serum lipopolysaccharide and liver pro-inflammatory cytokine expression. Overall this shows that gut microbiota members can use dietary fibre to generate beneficial metabolites to suppress metabolic disease.

Citing Articles

Emerging insights into the gut microbiota as a key regulator of immunity and response to immunotherapy in hepatocellular carcinoma.

Ren S, Zhang Y, Wang X, Su J, Wang X, Yuan Z Front Immunol. 2025; 16:1526967.

PMID: 40070843 PMC: 11893557. DOI: 10.3389/fimmu.2025.1526967.


Early-life antibiotic exposure aggravates hepatic steatosis through enhanced endotoxemia and lipotoxic effects driven by gut .

Zhang X, Chan D, Zhu J, Sin D, Peng Y, Wong M MedComm (2020). 2025; 6(3):e70104.

PMID: 39968496 PMC: 11832435. DOI: 10.1002/mco2.70104.


Antimicrobial peptide AP2 ameliorates Salmonella Typhimurium infection by modulating gut microbiota.

Li L, Mo Q, Wan Y, Zhou Y, Li W, Li W BMC Microbiol. 2025; 25(1):64.

PMID: 39910418 PMC: 11796240. DOI: 10.1186/s12866-025-03776-0.


Dietary Influences on Gut Microbiota and Their Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Hamamah S, Iatcu O, Covasa M Nutrients. 2025; 17(1.

PMID: 39796579 PMC: 11722922. DOI: 10.3390/nu17010143.


Intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis through the gut-liver axis.

Zhang X, Lau H, Ha S, Liu C, Liang C, Lee H Nat Metab. 2025; 7(1):102-119.

PMID: 39779889 PMC: 11774752. DOI: 10.1038/s42255-024-01177-7.


References
1.
Estes C, Anstee Q, Arias-Loste M, Bantel H, Bellentani S, Caballeria J . Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030. J Hepatol. 2018; 69(4):896-904. DOI: 10.1016/j.jhep.2018.05.036. View

2.
Nicolucci A, Hume M, Martinez I, Mayengbam S, Walter J, Reimer R . Prebiotics Reduce Body Fat and Alter Intestinal Microbiota in Children Who Are Overweight or With Obesity. Gastroenterology. 2017; 153(3):711-722. DOI: 10.1053/j.gastro.2017.05.055. View

3.
Koopman N, Molinaro A, Nieuwdorp M, Holleboom A . Review article: can bugs be drugs? The potential of probiotics and prebiotics as treatment for non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2019; 50(6):628-639. DOI: 10.1111/apt.15416. View

4.
Perez-Montes de Oca A, Julian M, Ramos A, Puig-Domingo M, Alonso N . Microbiota, Fiber, and NAFLD: Is There Any Connection?. Nutrients. 2020; 12(10). PMC: 7600472. DOI: 10.3390/nu12103100. View

5.
Nagashimada M, Honda M . Effect of Microbiome on Non-Alcoholic Fatty Liver Disease and the Role of Probiotics, Prebiotics, and Biogenics. Int J Mol Sci. 2021; 22(15). PMC: 8348401. DOI: 10.3390/ijms22158008. View